Column 1 0 Purpose of capital - see 3B announcement. No mention of last point below in original announcement.....
• To continue of our ongoing clinical development of IMP321;
- • To continue our preclinical development of IMP761;
- • For general corporate purposes;
- • We may also use a portion of the net proceeds to acquire or invest in businesses, products and technologies that we view as complementary to our own.
IMMP, page-12
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.015(5.26%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.8¢ | 29.0¢ | $833.7K | 2.793M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 258479 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 221018 | 27 |
View Market Depth
| Last trade - 15.13pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
